Positive opinion on two medicines for him coronavirus – the Ronapreve and Regkirona – which the Commission identifies as promising in the context of the EU strategy for the treatment of Covid-19, issued on Thursday by the European Medicines Agency (EMA).
These are medicines that can be taken at early stages of infection, based on antiviral monoclonal antibodies, broadcasts by ΑΠΕ ΜΠΕ.
Welcoming this development, the Commissioner for Health and Food Safety Stella Kyriakidou “With COVID-19 infections on the rise in almost all Member States, it is reassuring to see promising treatments being developed as part of our coronavirus treatment strategy,” he said.
“Today we are taking an important step forward towards our goal of approval up to five new drugs in the EU by the end of the year “, he added.
Access to new medicines through EU joint procurement
Ms. Kyriakidou underlined that “o vaccination remains the key tool in the fight against COVID-19, protection against infections, hospitalization, loss of life and long-term disease consequences. “While the EU has one of the highest vaccination rates in the world, people will continue to get sick and need safe and effective treatments to fight the infection and improve the outlook not only for faster recovery but also for survival.”
Thus, “as part of our treatment strategy, we also support Member States having access to new medicines through our joint procurement in the EU. Two procurement agreements have already been concluded so far and negotiations are underway for more treatments for COVID-19 being evaluated by the EMA.
At the same time, he pointed out that “the EMA is evaluating today another six medicines which could be approved soon, provided that the final data show their quality, safety and effectiveness. This rapid progress in the context of our ambitious treatment strategy shows what a strong European Health Union can offer “.
Finally, the Health Commissioner stressed that “vaccination is the only preventive way out from the crisis “.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
